Responsible and accountable to lead the company's overarching clinical strategy for new and existing products, integrating regulatory, clinical, and commercial considerations into a unified evidence roadmap.
Define scientific priorities and ensure alignment across clinical needs, commercial opportunity, and corporate goals.
Architect the clinical narrative that underpins product differentiation - shaping how evidence supports indications, labeling, reimbursement, and clinical adoption.
Translate corporate strategy and innovation priorities into clinical development and evidence-generation strategies that accelerate product approval, drive market access, and influence clinical practice - across hardware, software, AI, and clinical services.
Partner with Product Management, Advanced Technologies, Medical Safety & Clinical Oversight, R&D, and Health Economics & Value Insights, to align product roadmaps with clinical pathways, ensuring that evidence needs are embedded from concept through commercialization.
Anticipate evolving clinical, regulatory, and payer landscapes and design evidence strategies that position the company as a leader in cardiac diagnostics and digital health.
Product Clinical Development Function
Responsible and accountable to define and validate the clinical use cases for future products, based across unmet clinical needs and gaps, but defining hardware, software, and AI features, functions and capabilities required to serve these clinical use cases in relevant markets.
Evidence Generation Function
Lead the design and execution of pivotal FDA and global regulatory studies, ensuring methodological rigor, op
Benefits
Health insuranceVision insurance
Additional Information
Career-defining. Life-changing.
At iRhythm, you'll have the opportunity to grow your skills and your career while impacting the lives of people around the world. iRhythm is shaping a future where everyone, everywhere can access the best possible cardiac health solutions. Every day, we collaborate, create, and constantly reimagine what's possible. We think big and move fast, driven by our commitment to put patients first and improve lives. We need builders like you. Curious and innovative problem solvers looking for the chance to meaningfully shape the future of cardiac health, our company, and your career
About This Role:
Vice President, Clinical Development, Evidence, and Strategy
Position Summary
The Vice President of Clinical Development, Evidence, and Strategy will be responsible for leading the company's overall global clinical strategy, clinical positioning, differentiation, and the pre- and postmarket evidence generation portfolio; and for architecting how evidence informs product value, regulatory strategy, and competitive positioning. The leader will be critical member of the group that determines the clinical roadmap of the business across hardware, software, AI, and services. This leader will steward the company's global clinical research, clinical development (including AI products), real-world evidence, and commercial clinical research operations, uniting scientific, statistical, and operational capabilities into a cohesive enterprise that delivers clinical differentiation and commercial impact.
Reporting to the Chief Medical & Scientific Officer, this leader will manage the Advanced Technologies team, and will set the strategic vision for the product and service portfolio and roadmap including discovery work, upstream (emerging) technologies, and launched and in-market products. This includes defining and validating the clinical use cases, which are triangulated across clinical need, technical feasibility, and commercial opportunity. The leader will define and execute on how clinical evidence is generated, integrated, and communicated from early first-in-human studies and regulatory trials to post-market evidence, payer-focused outcomes research, and real-world data programs. They will define how evidence shapes product value propositions, informs clinical and regulatory pathways, differentiates the portfolio in competitive markets, and drives market access, adoption, and guideline inclusion. The executive will be responsible for management of pivotal clinical studies, site-based clinical studies, real-world evidence and comparative effectiveness strategies, the investigator-initiated research program, academic research partnerships, clinical support of regulatory submissions; ensuring high-quality execution, scientific rigor, and alignment with business and regulatory objectives. A key focus will be AI software medical devices.
This leader will bring deep clinical trial expertise in cardiology, cardiac arrhythmias, and artificial intelligence and the strategic vision to translate evidence into market leadership, including experience in pivotal FDA studies, combined with scientific acumen and proven ability to generate real-world data insights that advance product claims, market access, and patient outcomes.
Irhythmtech · Remote